Tech Company Financing Transactions
Prism Pharmaceuticals Funding Round
On 6/30/2007, Prism Pharmaceuticals raised $7.5 million in investment from EW Healthcare Partners.
Transaction Overview
Company Name
Announced On
6/30/2007
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
EW Healthcare Partners (James Currie)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1016 West Ninth Avenue 130
King of Prussia, PA 19406
USA
King of Prussia, PA 19406
USA
Phone
Website
Email Address
Overview
Prism will become a leading specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Warren Copper
Chief Financial Officer
Stanley Musial
Chief Operating Officer
Kathleen DeLawrence
VP - Regulatory Affairs
Daniel Cushing
Browse more venture capital transactions:
Prev: 6/30/2007: RF Nano venture capital transaction
Next: 7/2/2007: Accord Biomaterials venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs